세계의 의료용 3D 바이오 프린팅 시장 (2022~2032) : 제품 및 솔루션별 (바이오 프린터, 소모품 및 부속품, 소프트웨어 및 서비스), 기술별 (압출 기반 바이오 프린팅, 잉크젯 기반 바이오 프린팅, 레이저 보조 바이오 프린팅, 기타), 용도별 (조직 공학 및 재생 의료, 신약 개발, 기타), 최종 용도별 (바이오 테크놀로지 및 제약 기업, 학술 및 연구 기관, 기타), 지역별

Chapter 1. Global 3D Bioprinting in Medical Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Global 3D Bioprinting in Medical Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Products and Solutions
2.3.2. By Technology
2.3.3. By Application
2.3.4. By End User
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global 3D Bioprinting in Medical Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global 3D Bioprinting in Medical Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global 3D Bioprinting in Medical Market Size & Forecasts by Products and Solutions 2022-2032
5.1. Bioprinters
5.2. Consumables and accessories
5.3. Software and services
Chapter 6. Global 3D Bioprinting in Medical Market Size & Forecasts by Technology 2022-2032
6.1. Extrusion based bioprinting
6.2. Inkjet based bioprinting
6.3. Laser assisted bioprinting
6.4. Others
Chapter 7. Global 3D Bioprinting in Medical Market Size & Forecasts by Application 2022-2032
7.1. Tissue engineering and regenerative medicine
7.2. Drug discovery and development
7.3. Others
Chapter 8. Global 3D Bioprinting in Medical Market Size & Forecasts by End User 2022-2032
8.1. Biotechnology and pharmaceutical companies
8.2. Academic and research institutes
8.3. Others
Chapter 9. Global 3D Bioprinting in Medical Market Size & Forecasts by Region 2022-2032
9.1. North America 3D Bioprinting in Medical Market
9.1.1. U.S. 3D Bioprinting in Medical Market
9.1.1.1. Products and Solution breakdown size & forecasts, 2022-2032
9.1.1.2. Technology breakdown size & forecasts, 2022-2032
9.1.1.3. Application breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada 3D Bioprinting in Medical Market
9.2. Europe 3D Bioprinting in Medical Market
9.2.1. U.K. 3D Bioprinting in Medical Market
9.2.2. Germany 3D Bioprinting in Medical Market
9.2.3. France 3D Bioprinting in Medical Market
9.2.4. Spain 3D Bioprinting in Medical Market
9.2.5. Italy 3D Bioprinting in Medical Market
9.2.6. Rest of Europe 3D Bioprinting in Medical Market
9.3. Asia-Pacific 3D Bioprinting in Medical Market
9.3.1. China 3D Bioprinting in Medical Market
9.3.2. India 3D Bioprinting in Medical Market
9.3.3. Japan 3D Bioprinting in Medical Market
9.3.4. Australia 3D Bioprinting in Medical Market
9.3.5. South Korea 3D Bioprinting in Medical Market
9.3.6. Rest of Asia Pacific 3D Bioprinting in Medical Market
9.4. Latin America 3D Bioprinting in Medical Market
9.4.1. Brazil 3D Bioprinting in Medical Market
9.4.2. Mexico 3D Bioprinting in Medical Market
9.4.3. Rest of Latin America 3D Bioprinting in Medical Market
9.5. Middle East & Africa 3D Bioprinting in Medical Market
9.5.1. Saudi Arabia 3D Bioprinting in Medical Market
9.5.2. South Africa 3D Bioprinting in Medical Market
9.5.3. Rest of Middle East & Africa 3D Bioprinting in Medical Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. 3D Systems Corporation
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Desktop Metal, Inc.
10.3.3. Organovo Holdings, Inc.
10.3.4. Cyfuse Biomedical K.K
10.3.5. Medprin Biotech GmbH
10.3.6. Advanced Solutions, Inc.
10.3.7. CollPlant Biotechnologies Ltd
10.3.8. REGEMAT 3D S.L
10.3.9. The Bio Convergence Company
10.3.10. Shining 3D
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes